Patients with Ankylosing Spondylitis and Low Disease Activity because of Anti-TNF-Alpha Therapy Have Higher TRAIL Levels Than Controls: A Potential Compensatory Effect

Objective. TRAIL is a potential biomarker of cardiovascular (CV) disease. Ankylosing spondylitis (AS) is a chronic inflammatory disease associated with metabolic syndrome (MeS) and accelerated atherosclerosis. We assessed whether disease activity, systemic inflammation, and MeS features were associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Genre, Fernanda, López-Mejías, Raquel, Rueda-Gotor, Javier, Miranda-Filloy, José A., Ubilla, Begoña, Carnero-López, Beatriz, Palmou-Fontana, Natalia, Gómez-Acebo, Inés, Blanco, Ricardo, Pina, Trinitario, Ochoa, Rodrigo, González-Juanatey, Carlos, Llorca, Javier, González-Gay, Miguel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055458/
https://www.ncbi.nlm.nih.gov/pubmed/24976690
http://dx.doi.org/10.1155/2014/798060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055458/
https://www.ncbi.nlm.nih.gov/pubmed/24976690
http://dx.doi.org/10.1155/2014/798060

Ejemplares similares